Thalassemia

Thalassemia is a genetic blood disorder characterized by the abnormal production of hemoglobin, leading to anemia and other health complications. It results from mutations in the genes responsible for hemoglobin production, causing red blood cells to break down prematurely. Symptoms can range from mild to severe, including fatigue, weakness, and pale skin. Management of thalassemia often involves regular blood transfusions and iron chelation therapy to remove excess iron from the body. Advances in gene therapy and other treatments are being explored to improve the quality of life for those affected by thalassemia.
 

    Related Conference of Thalassemia

    February 24-25, 2025

    4th European Congress on Hematology

    Madrid, Spain
    July 07-08, 2025

    23rd World Hematology Congress

    Zurich, Switzerland

    Thalassemia Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in